University of Cambridge > > Bradford Hill Seminars > The future of cancer screening: stratified, pan, both or neither?

The future of cancer screening: stratified, pan, both or neither?

Add to your list(s) Download to your calendar using vCal

  • UserProfessor Peter Sasieni, King’s Clinical Trials Unit, King’s College London World_link
  • ClockWednesday 11 May 2022, 13:00-14:00
  • House Webinar (via Zoom online).

If you have a question about this talk, please contact Paul Browne.

Register in advance for this free online seminar:

After registering, you will receive a confirmation email containing information about joining the meeting.

In this seminar Professor Peter Sasieni will briefly review the current landscape regarding cancer screening. He will then consider the potential for stratifying screening using either polygenic risk scores to differentiate between those with a low, average, or high risk of cancer, or the post-test risk of cancer to offer stratified management. Finally, he will review the potential to expand the scope of cancer screening by adding either new single-site screening programmes or a multi-cancer early detection test. The question of whether a pan-cancer screening test would dissipate the benefit of using polygenic risk scores to stratify screening will also be discussed as will the challenges of reducing screening as risk changes.

This talk is part of the Bradford Hill Seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity